PT Indofarma Tbk reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was IDR 339,027.45 million compared to IDR 373,204.22 million a year ago. Net loss was IDR 51,182.65 million compared to net income of IDR 1,819.43 million a year ago. Basic loss per share from continuing operations was IDR 16.51 compared to basic earnings per share from continuing operations of IDR 0.59 a year ago.